Interleukin-6 (IL-6): Is a marker for cardiovascular disease in patients with diabetic nephropathy

被引：0
|
作者：
Silva, A. [1 ]
Baptista, A. [1 ]
Neves, P. [1 ]
机构：
[1] Hosp Distrital Faro, Faro, Portugal
来源：
CIRCULATION | 2008年 / 118卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E204 / E204
页数：1
相关论文
共 50 条
  • [41] SOLUBLE INTERLEUKIN-6 (IL-6) RECEPTOR AUGMENTS CENTRAL EFFECTS OF IL-6 IN-VIVO
    SCHOBITZ, B
    PEZESHKI, G
    POHL, T
    HEMMANN, U
    HEINRICH, PC
    HOLSBOER, F
    REUL, JMHM
    FASEB JOURNAL, 1995, 9 (08): : 659 - 664
  • [42] Analysis of the Effect of Serum Interleukin-6 (IL-6) and Soluble IL-6 Receptor Levels on Survival of Patients with Colorectal Cancer
    Yeh, Kun-Yun
    Li, Ying-Ying
    Hsieh, Ling-Ling
    Lu, Chang-Hsien
    Chou, Wen-Chi
    Liaw, Chuang-Chi
    Tang, Rei-Ping
    Liao, Shuen-Kuei
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2010, 40 (06) : 580 - 587
  • [43] The Endothelium Secretes Interleukin-6 (IL-6) and Induces IL-6 and Aldosterone Generation by Adrenocortical Cells
    Willenberg, H. S.
    Ansurudeen, I.
    Schebesta, K.
    Haase, M.
    Wess, B.
    Schinner, S.
    Raffel, A.
    Schott, M.
    Scherbaum, W. A.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2008, 116 : S70 - S74
  • [44] HUMAN MARROW STROMAL CELLS - RESPONSE TO INTERLEUKIN-6 (IL-6) AND CONTROL OF IL-6 EXPRESSION
    NEMUNAITIS, J
    ANDREWS, DF
    MOCHIZUKI, DY
    LILLY, MB
    SINGER, JW
    BLOOD, 1989, 74 (06) : 1929 - 1935
  • [45] Induction of interleukin-6 (IL-6) autoantibodies through vaccination with an engineered IL-6 receptor antagonist
    Laura Ciapponi
    Domenico Maione
    Ariane Scoumanne
    Patrizia Costa
    Morten Bagge Hansen
    Morten Svenson
    Klaus Bendtzen
    Tonino Alonzi
    Giacomo Paonessa
    Riccardo Cortese
    Gennaro Ciliberto
    Rocco Savino
    Nature Biotechnology, 1997, 15 : 997 - 1001
  • [46] Induction of interleukin-6 (IL-6) autoantibodies through vaccination with an engineered IL-6 receptor antagonist
    Ciapponi, L
    Maione, D
    Scoumanne, A
    Costa, P
    Hansen, MB
    Svenson, M
    Bendtzen, K
    Alonzi, T
    Paonessa, G
    Cortese, R
    Ciliberto, G
    Savino, R
    NATURE BIOTECHNOLOGY, 1997, 15 (10) : 997 - 1001
  • [47] Interleukin-6 and highly sensitive C reactive protein as a marker of inflammation in diabetic nephropathy
    Ahlawat, R. S.
    Choudhary, N.
    Misra, T. K.
    NEPHROLOGY, 2008, 13 : A13 - A13
  • [48] Interleukin-6 (IL-6)/soluble interleukin-6 receptor (sIL-6R) complex, but not IL-6 or sIL-6R alone, inhibits myocardial apoptosis
    Matsushita, K
    Iwanaga, S
    Oda, T
    Kimura, K
    Shimada, M
    Tanaka, M
    Matsumura, S
    CIRCULATION, 2002, 106 (19) : 306 - 306
  • [49] IN-SITU HYBRIDIZATION OF INTERLEUKIN-6 IN DIABETIC NEPHROPATHY
    SUZUKI, D
    MIYAZAKI, M
    NAKA, R
    KOJI, T
    YAGAME, M
    JINDE, K
    ENDOH, M
    NOMOTO, Y
    SAKAI, H
    DIABETES, 1995, 44 (10) : 1233 - 1238
  • [50] Serum interleukin-6 (IL-6) and interleukin-4 (IL-4) in patients with multiple myeloma (MM)
    Kyrstsonis, MC
    Dedoussis, G
    Baxevanis, C
    Stamatelou, M
    Maniatis, A
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 92 (02) : 420 - 422
12345